22 September 2004 in Wound Repair and Regeneration
27 September 2021 in Cell Reports Methods
With the recent advancements in genome editing, next-generation sequencing (NGS), and scalable cloning techniques, scientists can now conduct genetic screens at unprecedented levels of scale and precision. With such a multitude of technologies, there is a need for a simple yet comprehensive pipeline to enable systematic mammalian genetic screening. In this study, we develop unique algorithms for target identification and a toxin-less Gateway cloning tool, termed MegaGate, for library cloning which, when combined with existing genetic perturbation methods and NGS-coupled readouts, enable versatile engineering of relevant mammalian cell lines. Our integrated pipeline for sequencing-based target ascertainment and modular perturbation screening (STAMPScreen) can thus be utilized for a host of cell state engineering applications.
22 October 2021 in STAR Protocols
Gateway cloning employs the use of the ccdb toxin and has low colony numbers, making it difficult to apply at scale to clone libraries of cDNA vectors. In this protocol, we describe MegaGate, a toxin-less Gateway technology capable of robust cDNA library cloning that is efficient, cheap, and scalable. MegaGate eliminates the ccdb toxin used in Gateway recombinase cloning and instead utilizes meganuclease-mediated digestion to eliminate background vectors during cloning and is 99.8% efficient with high colony numbers.
18 November 2026 in Nature
Current understanding of the host tissue response to solid tumours is largely based on investigations of tumour types in isolation1. Given the breadth and diversity of human tumour pathology and contributions of tumour microenvironment (TME) cells to disease progression, pan-cancer analysis is needed to bridge major themes of stromal and immune cell evolution. To date, however, efforts to compare the TME response across cancers have been limited in scope2,3. Here we conduct a comprehensive pan-cancer analysis by algorithmically screening thousands of publicly available single-cell transcriptomic datasets for stromal and immune signatures across species and tissue types. We demonstrate conserved hallmarks of host cell transcriptional programming in response to malignancy across 42 cancer types in more than 2,000 human and mouse tumour samples. These findings are codified as an interactive web atlas ( tmeatlas.stanford.edu ) and software package (scTME) that will serve as practical resources for the systematic interrogation of the TME in tumours.
14 October 2026 in Nature Aging